NCT01564277 2018-01-09
Rasburicase and Allopurinol in Treating Patients With Hematologic Malignancies
Roswell Park Cancer Institute
Phase 2 Terminated
Clinical Trials
5 trialsNCT00057811 2014-09-19
Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma
Children's Oncology Group
Phase 2 Completed
NCT00664144 2012-03-07
GRAAL2
Sanofi
Phase 2 Terminated
NCT00631579 2009-10-02
Rasburicase as a Uricolytic Therapy for Hyperuricemia in Patients With Leukemia or Lymphoma
Sanofi
Phase 2 Completed
NCT00290992 2009-03-30
Rasburicase for Hyperuricemia
Sanofi
Phase 2 Completed